SARS-CoV-2 S protein (126-264 aa) Polyclonal antibody
SARS-CoV-2 S protein (126-264 aa) Polyclonal Antibody for ELISA
验证数据展示
经过测试的应用
Positive ELISA detected in | Recombinant protein |
推荐稀释比
Application | Dilution |
---|---|
Enzyme-linked Immunosorbent Assay (ELISA) | ELISA : |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 1 publications below |
IP | See 1 publications below |
产品信息
28869-1-AP targets SARS-CoV-2 S protein (126-264 aa) in WB, IP, ELISA applications and shows reactivity with Virus samples.
Tested Applications | ELISA Application Description |
Cited Applications | WB, IP |
Tested Reactivity | Virus |
Immunogen | SARS-CoV-2 S protein (126-264 aa) fusion protein Ag30679 种属同源性预测 |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Full Name | SARS-CoV-2 Spike Protein |
Synonyms | SARS-CoV-2 Spike Glycoprotein (126-264 aa), spike, spike protein |
Calculated Molecular Weight | 141 kDa |
GenBank Accession Number | NC_045512 |
Gene Symbol | SARS-COV-2 |
Gene ID (NCBI) | 43740568 |
RRID | AB_2881225 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). 28869-1-AP is specific for spike protein of SARS-COV-2, that antigen region is 126-264aa.